Feasibility study of TS-1 additional therapy for the triple-negative breast cancer received neoadjuvant or adjuvant chemotherapy (SBCCSG14).K Futsuhara,Kenichi Inoue,Shigenori Nagai,Tsuyoshi Saito,Takashi Sakurai,Kei Kimizuka, Masafumi Kurozumi,Toshio Tabei,Hirofumi Yamada,Masato Kojima,Satoshi Hata,Yasuo Yamazakimag(2014)引用 23|浏览17暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要